Lifestance Health Group Inc (LFST) Peer Comparison
$14.08
$-0.07
(-0.49%)
As on 13-Nov-2026 16:00EST
Market cap
$5,353 Mln
Revenue (TTM)
$1,677 Mln
P/E Ratio
78.2
P/B Ratio
3.6
Div. Yield
0 %
Edit
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
5,353 | 13,834 | 10,992 | 7,105 | 6,020 |
Revenue ($ Mln) |
1,677 | 6,338 | 5,674 | 2,661 | 2,384 |
Net Profit ($ Mln) |
71.91 | 644.40 | 399.12 | 282.40 | -22.38 |
Net Margin (%) |
4.29 | 10.17 | 7.03 | 10.61 | -0.94 |
RoE (%) |
4.84 | 16.39 | 16.19 | 33.04 | -6.29 |
Price to Earnings |
78.22 | 22.56 | 28.04 | 26.25 | -- |
Price-To-Book |
3.60 | 5.15 | 4.25 | 8.28 | 5.34 |
Income Statement ($ Mln)
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,676.89 | 6,338.10 | 5,674.31 | 2,661.04 | 2,384.32 |
|
Cost of Revenue
|
1,100.22 | 3,896.00 | 4,838.38 | 1,818.79 | 2,150.83 |
|
Gross Profit
|
461.10 | 2,564.90 | 799.45 | 758.34 | 90.80 |
|
Operating Expenses
|
472.57 | 1,280.70 | 326.77 | 471.57 | 191.88 |
|
Operating Profit (EBIT)
|
104.10 | 1,161.40 | 509.16 | 370.86 | 88.41 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
89.82 | 1,065.80 | 532.53 | 382.32 | 42.22 |
|
Provision for Tax
|
17.92 | 218.80 | 133.02 | 99.92 | 17.68 |
|
Profit after Tax (Net Income)
|
71.91 | 644.40 | 399.12 | 282.40 | -22.38 |
|
Minority Interest
|
0.00 | -217.90 | -0.39 | 0.00 | -46.91 |
|
Consolidated Profit
|
0.00 | 145.70 | 0.00 | 76.75 | 0.00 |
Liabilities ($ Mln)
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,492.39 | 2,681.20 | 2,559.31 | 861.42 | 1,121.30 |
|
Minority Interest
|
0.00 | -217.90 | -0.39 | 0.00 | -46.91 |
|
Non-Current Liabilities
|
432.76 | 3,077.90 | 2,472.09 | 526.08 | 2,126.88 |
|
Current Liabilities
|
261.13 | 927.40 | 962.91 | 330.93 | 716.64 |
|
Total Liabilities
|
2,203.93 | 7,089.70 | 5,462.97 | 1,538.19 | 3,758.56 |
Assets ($ Mln)
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,809.50 | 6,553.50 | 4,843.51 | 1,352.71 | 3,211.96 |
|
Current Assets
|
376.78 | 1,013.00 | 1,154.88 | 365.73 | 1,068.44 |
|
Total Assets
|
2,203.93 | 7,089.70 | 5,462.97 | 1,538.19 | 3,758.56 |
|
Total Debt*
|
461.02 | 2,803.40 | 2,287.65 | 392.19 | 2,172.62 |
|
Net Current Assets
|
115.65 | 85.60 | 191.97 | 34.79 | 351.80 |
Cashflow ($ Mln)
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
146.15 | 1,175.60 | 564.27 | 388.27 | 298.82 |
|
Cash Flow from Investing Activities
|
-36.13 | -762.80 | -513.18 | -59.34 | -343.87 |
|
Cash from Financing Activities
|
-15.96 | -433.00 | -11.81 | -432.77 | 72.21 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
0.53 | 11.40 | 6.75 | 22.26 | -0.67 |
|
ROE (%)
|
4.84 | 16.39 | 16.19 | 33.04 | -6.29 |
|
ROA (%)
|
2.98 | 7.99 | 6.13 | 14.24 | -0.48 |
|
EBIT Margin (%)
|
5.94 | 18.82 | 9.53 | 14.23 | 4.90 |
|
Net Margin (%)
|
4.29 | 10.17 | 7.03 | 10.61 | -0.94 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
22.62 | 9.36 | 17.49 | 5.15 | 21.06 |
|
EBIT Growth (%)
|
1,440.34 | 16.63 | 22.99 | 1.29 | 26.31 |
|
Net Profit Growth (%)
|
888.72 | 19.11 | 21.61 | 1.29 | -76.08 |
|
EPS Growth (%)
|
868.01 | 21.08 | 20.07 | 10.23 | -71.54 |
|
Book Value Growth (%)
|
-0.62 | 15.90 | 20.05 | -11.47 | -0.05 |
Valuation Ratios
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
286.40 | 19.12 | 30.03 | 22.57 | -287.63 |
|
Price / Book Value
|
3.60 | 5.15 | 4.25 | 8.28 | 5.34 |
|
Dividend Yield (%)
|
0.00 | 0.55 | 0.14 | 0.45 | 0.00 |
|
EV/EBITDA
|
34.06 | 10.57 | 22.04 | 16.08 | 24.09 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.17 | 0.95 | 0.08 | 0.27 | 1.15 |
|
Short term debt to equity ratio
|
0.03 | 0.03 | 0.05 | 0.05 | 0.09 |
|
Current Ratio
|
1.44 | 1.09 | 1.20 | 1.11 | 1.49 |
|
Quick Ratio
|
1.44 | 1.09 | 1.20 | 1.08 | 1.49 |
|
Interest Coverage
|
10.17 | 9.39 | 66.70 | 78.72 | 1.57 |
Operating Efficiency Ratios
| Lifestance Health Group Inc (LFST) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
7.21 | 11.23 | 11.72 | 9.58 | 10.67 |
|
Asset Turnover
|
0.70 | 0.79 | 0.87 | 1.34 | 0.52 |
|
Receivable days
|
29.20 | 37.48 | 43.58 | 25.53 | 39.44 |
|
Inventory Days
|
-- | -- | -- | 1.62 | -- |
|
Payable days
|
2.53 | 18.92 | 8.42 | 11.20 | 23.39 |
|
Cash Conversion Cycle
|
-- | -- | -- | 15.96 | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
